Fierce Biotech White Logo Fierce Biotech White Logo
Webinar

Alzheimer’s Outlook – Neuroinflammation, The Next Step

ET
60 minutes

What have we learned about Alzheimer’s disease over the last five years? Major breakthroughs have been made recently in the research and development of this complex, memory-robbing disease. With a stronger understanding of disease pathology, new therapeutic pathways and the launch of the first disease-modifying treatments, what are the next developments?

In this webinar, we’ll hear about:

  • the latest research into the causes of Alzheimer’s disease
  • the different therapeutic pathways being explored
  • drugs in development and their pharmacological targets
  • the pathophysiological effects of neuroinflammation in Alzheimer’s disease

If you are a neurodegenerative disease researcher or clinician or study brain health or are a caregiver for someone living with Alzheimer’s disease, join this webinar to learn what the future holds in Alzheimer’s disease therapeutic development.

Speakers

inmed

Phyllis Ferrell, DrPH, MBA

Dr. Ferrell is the Chief Impact Officer at StartUp Health’s Alzheimer’s Moonshot. Formerly, she was the Global Head of External Engagement for Alzheimer’s disease and neurodegeneration at Eli Lilly & Company, where she previously served as the leader of the Global Alzheimer’s disease development team. 

inmed

Eric Hsu, PhD

Dr. Hsu is the Senior Vice President of Preclinical Research and Development at InMed Pharmaceuticals where he leads the Alzheimer’s disease R&D program. He has 20+ years of research experience and is an expert in gene transfer and gene expression.

inmed

David Morgan, PhD

Dr. Morgan is Director of the Alzheimer’s Alliance and MSU Foundation Professor of Translational Neuroscience at Michigan State University. Dr. Morgan’s research interests are Alzheimer’s disease, aging and brain function. He is internationally recognized for his work on immunotherapy and gene therapy to treat the Alzheimer-related pathologies.

inmed

Marwan Sabbagh, MD

Dr. Sabbagh is the Moreno Family Chair for Alzheimer’s Research and Vice Chairman for Research and Professor of Neurology at the Barrow Neurological Institute in Phoenix Arizona. Dr. Sabbagh is first and foremost an experienced clinician, whose practice as a geriatric neurologist is world renown. He has also been a leading investigator for Alzheimer’s clinical trials for over 25 years.  

inmed

Barry Greenberg, PhD

Dr. Greenberg is an Associate Professor in the Department of Neurology at the Johns Hopkins University School of Medicine, where he is leading the development of an Alzheimer’s Disease Translational Center, with the objective of integrating basic and clinical research to enable the development of effective therapies that will delay or prevent Alzheimer’s at its earliest stages. 

Register here!

Date/Time:
ET
Duration:
60 minutes